JPH10502073A - ブロメラインの医療への使用 - Google Patents
ブロメラインの医療への使用Info
- Publication number
- JPH10502073A JPH10502073A JP8502932A JP50293296A JPH10502073A JP H10502073 A JPH10502073 A JP H10502073A JP 8502932 A JP8502932 A JP 8502932A JP 50293296 A JP50293296 A JP 50293296A JP H10502073 A JPH10502073 A JP H10502073A
- Authority
- JP
- Japan
- Prior art keywords
- bromelain
- cells
- preparation
- cell
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9412711.5 | 1994-06-24 | ||
GB9412711A GB9412711D0 (en) | 1994-06-24 | 1994-06-24 | Medical use of bromelain |
PCT/GB1995/001501 WO1996000082A1 (en) | 1994-06-24 | 1995-06-26 | Medical use of bromelain |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10502073A true JPH10502073A (ja) | 1998-02-24 |
Family
ID=10757263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8502932A Pending JPH10502073A (ja) | 1994-06-24 | 1995-06-26 | ブロメラインの医療への使用 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0766565A1 (xx) |
JP (1) | JPH10502073A (xx) |
KR (1) | KR970703784A (xx) |
CN (1) | CN1151119A (xx) |
AU (1) | AU2749395A (xx) |
CA (1) | CA2193654A1 (xx) |
FI (1) | FI965204A (xx) |
GB (1) | GB9412711D0 (xx) |
IL (1) | IL114331A0 (xx) |
NO (1) | NO965564L (xx) |
TW (1) | TW403654B (xx) |
WO (1) | WO1996000082A1 (xx) |
ZA (1) | ZA955292B (xx) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017533948A (ja) * | 2014-11-13 | 2017-11-16 | マイ,ジェニファー | 癌の治療のための新規組成物 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9526691D0 (en) * | 1995-12-29 | 1996-02-28 | Cortecs Ltd | Medical use of proteases |
EP1012305A1 (en) * | 1997-02-25 | 2000-06-28 | Cortecs (UK) Limited | Component of bromelain |
WO1998038319A1 (en) * | 1997-02-25 | 1998-09-03 | Cortecs (Uk) Limited | Component of bromelain |
US20020102253A1 (en) * | 1997-02-25 | 2002-08-01 | Mynott Tracey Lehanne | Component of bromelain |
NO304766B1 (no) | 1997-06-16 | 1999-02-08 | Sintef | Fingeravtrykksensor |
DE19726255C2 (de) * | 1997-06-20 | 2000-03-16 | Mucos Pharma Gmbh & Co | Beeinflussung von Cytokinen durch proteolytische Enzyme und Rutosid |
DE19726254C2 (de) * | 1997-06-20 | 1999-10-21 | Mucos Pharma Gmbh & Co | Toleranzinduktion durch Proteasen |
DE19726244C2 (de) * | 1997-06-20 | 2000-03-02 | Mucos Pharma Gmbh & Co | Verwendung proteolytischer Enzyme und Rutosid zur Vorbeugung bzw. Behandlung der Transplantatabstoßung |
GB9713667D0 (en) * | 1997-06-27 | 1997-09-03 | Cortecs Ltd | Enhancement of intestinal permeability |
GB9819137D0 (en) * | 1998-09-02 | 1998-10-28 | Cortecs Uk Ltd | Component of bromelain |
GB9819138D0 (en) * | 1998-09-02 | 1998-10-28 | Cortecs Uk Ltd | Nucleic acids and proteins from pineapple stem |
DE19847114A1 (de) * | 1998-10-13 | 2000-04-20 | Mucos Pharma Gmbh & Co | Beeinflussung von hyperaktiven T-Zellen durch proteolytische Enzyme |
WO2000035436A2 (en) * | 1998-12-16 | 2000-06-22 | Warner-Lambert Company | Treatment of arthritis with mek inhibitors |
DE19957318A1 (de) * | 1999-11-29 | 2001-06-21 | Mucos Pharma Gmbh & Co | Beeinflussung von TGF-Beta durch Proteolytische Enzyme |
DE10018980A1 (de) * | 2000-04-17 | 2001-11-08 | Mucos Pharma Gmbh & Co | Prophylaxe und Therapie von Diabetes mellitus I mit Hilfe proteolytischer Enzyme |
EP1208849B1 (en) * | 2000-11-28 | 2015-10-28 | URSAPHARM Arzneimittel GmbH | Use of bromelain for adjuvant therapy during wound healing process |
TW201419131A (zh) | 2012-11-09 | 2014-05-16 | Health & Life Co Ltd | 具語音輔助之生物感測裝置 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59225122A (ja) * | 1983-05-23 | 1984-12-18 | Kaken Pharmaceut Co Ltd | 悪液質治療改善剤 |
EP0421023B1 (de) * | 1989-10-06 | 1995-03-15 | MUCOS EMULSIONSGESELLSCHAFT m.b.H. | Katabolische Enzyme zur Induktion des Tumornekrose-Faktors (TNF) |
DE4302060A1 (de) * | 1993-01-26 | 1994-07-28 | Mucos Pharma Gmbh & Co | Verwendung von Bromelain zur Krebstherapie und/oder Metastasen-Prophylaxe |
GB9313188D0 (en) * | 1993-06-25 | 1993-08-11 | Cortecs Ltd | Medical use of enzymes |
-
1994
- 1994-06-24 GB GB9412711A patent/GB9412711D0/en active Pending
-
1995
- 1995-06-25 IL IL11433195A patent/IL114331A0/xx unknown
- 1995-06-26 CA CA002193654A patent/CA2193654A1/en not_active Abandoned
- 1995-06-26 CN CN95193767A patent/CN1151119A/zh active Pending
- 1995-06-26 WO PCT/GB1995/001501 patent/WO1996000082A1/en not_active Application Discontinuation
- 1995-06-26 ZA ZA955292A patent/ZA955292B/xx unknown
- 1995-06-26 JP JP8502932A patent/JPH10502073A/ja active Pending
- 1995-06-26 KR KR1019960707424A patent/KR970703784A/ko not_active Application Discontinuation
- 1995-06-26 AU AU27493/95A patent/AU2749395A/en not_active Abandoned
- 1995-06-26 EP EP95922672A patent/EP0766565A1/en not_active Withdrawn
- 1995-07-04 TW TW084106855A patent/TW403654B/zh active
-
1996
- 1996-12-23 NO NO965564A patent/NO965564L/no unknown
- 1996-12-23 FI FI965204A patent/FI965204A/fi unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017533948A (ja) * | 2014-11-13 | 2017-11-16 | マイ,ジェニファー | 癌の治療のための新規組成物 |
Also Published As
Publication number | Publication date |
---|---|
KR970703784A (ko) | 1997-08-09 |
NO965564D0 (no) | 1996-12-23 |
CN1151119A (zh) | 1997-06-04 |
FI965204A (fi) | 1997-02-21 |
TW403654B (en) | 2000-09-01 |
EP0766565A1 (en) | 1997-04-09 |
WO1996000082A1 (en) | 1996-01-04 |
AU2749395A (en) | 1996-01-19 |
FI965204A0 (fi) | 1996-12-23 |
CA2193654A1 (en) | 1996-01-04 |
IL114331A0 (en) | 1995-10-31 |
ZA955292B (en) | 1997-07-28 |
GB9412711D0 (en) | 1994-08-17 |
NO965564L (no) | 1997-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH10502073A (ja) | ブロメラインの医療への使用 | |
US20120058133A1 (en) | Inhibition of trna synthetases and therapeutic applications thereof | |
US9314485B2 (en) | Use of PI3K M-TOR and AKT inhibitors to induce FOXP3 expression and generate regulatory T cells | |
Fernandez‐Martin et al. | Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis | |
Mejri et al. | Intraperitoneal murine Echinococcus multilocularis infection induces differentiation of TGF‐β‐expressing DCs that remain immature | |
CN105073110B (zh) | 通过诱导分化成调节性t细胞和促进调节性t细胞增殖来抑制免疫应答的药物组合物 | |
Reinhard et al. | c‐Rel promotes type 1 and type 17 immune responses during Leishmania major infection | |
JP2010143945A (ja) | ブロメライン成分を含む製薬組成物及び同ブロメライン成分を薬剤の調製に使用する方法 | |
JP2022527338A (ja) | 多能性幹細胞の胸腺上皮細胞および胸腺上皮前駆細胞分化を促進する方法 | |
AU2003250892A1 (en) | Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors | |
US9663777B2 (en) | Component of bromelain | |
JP2000502697A (ja) | プロテアーゼの医療への使用 | |
US20100297123A1 (en) | Combination therapy to inhibit t cell effector function | |
MXPA97000209A (en) | Medical use of bromela | |
US20090142319A1 (en) | METHOD TO EXPAND nTREG CELLS USING PI-3K ANTAGONIST | |
US20070184046A1 (en) | Use of a phospholipase A2 for the preparation of pharmaceutical and/or cosmetic compositions for the local and/or systematic treatment and/or prevention of diseases and/or processes caused by intra- and extracellular pathogens expressing membrane phospholipids | |
US20110039791A1 (en) | Acetylcholinesterase (ache)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof | |
Armitage | PTPN22 Regulates Induced MHC-II Expression in Macrophages | |
WO2000014254A2 (en) | Component of bromelain | |
Gaddis | Cellular mechanisms involved in host responses to Porphyromonas gingivalis and its virulence factor Hemagglutinin B | |
Alic | Involvement of proteases and kinases in mast cell activation | |
Schneider | Unraveling The Paradoxical Impacts Of Toxoplasma Gondii On Dendritic Cell Stat1 Signaling | |
Evans III | Itk is a Dual Action Regulator of Immunoreceptor Signaling in the Innate and Adaptive Immune System: A Dissertation | |
Colombetti | Dissecting the Molecular Mechanisms Regulating Proliferation, Antigen Responsiveness, and Differentiation of CD4+ T Lymphocytes: A Central Role for the Mammalian Target of Rapamycin (mTor) | |
Creasy | Inflammatory Regulation of Cysteine Cathepsins |